Chemical activators of the protein "Or1e34" engage in a multifaceted mechanism aimed at influencing its activity. Among these activators, Resveratrol plays a pivotal role by acting on the Sirtuin pathway. This compound can activate Sirtuins, a class of deacetylases, which, in turn, can deacetylate specific target proteins. In the context of "Or1e34," the deacetylation of certain regulatory elements can lead to enhanced gene expression and function. Similarly, Forskolin exerts its impact through adenylate cyclase activation, resulting in elevated cyclic AMP (cAMP) levels. The increased cAMP can stimulate downstream signaling pathways, indirectly affecting the regulation of "Or1e34" by modulating its cellular environment. LY294002 takes a different approach by inhibiting the PI3K pathway, which can indirectly influence the "Or1e34" gene's activity. This inhibition alters the balance of signaling events in the cell, potentially leading to changes in the transcriptional regulation of "Or1e34." Furthermore, SB203580 intervenes by targeting p38 MAPK, which is intricately connected to various cellular processes, including gene expression. The modulation of p38 MAPK may indirectly impact the "Or1e34" gene's regulation, highlighting the complexity of the interplay between these chemicals and the protein's activity.
JAK Inhibitor I stands as a noteworthy activator, as it influences the JAK/STAT pathway, known to be associated with "Or1e34." By modulating this pathway, JAK Inhibitor I can potentially enhance the transcriptional regulation of the gene. Additionally, XAV939 actively participates by inhibiting the Wnt pathway, which can indirectly affect the activity of "Or1e34" through downstream signaling events. Bay 11-7082 takes on a unique role by inhibiting NF-κB activation. Its modulation can influence the regulation of "Or1e34" by altering the cellular response to inflammatory stimuli. DAPT targets the Notch signaling pathway, which has been linked to certain aspects of "Or1e34" regulation. Through the inhibition of Notch, DAPT can indirectly impact the gene's expression and function. Similarly, SB431542 intervenes by inhibiting the TGF-β receptor, potentially affecting the "Or1e34" gene's function by disrupting TGF-β signaling. GDC-0449 is instrumental as it antagonizes the Hedgehog pathway, which may have downstream effects on the "Or1e34" gene, considering its involvement in various cellular processes. In summary, these chemicals, by engaging with specific signaling pathways, can indirectly activate the "Or1e34" gene, impacting its transcriptional regulation and functional activation.
더보기
Items 11 to 12 of 12 total
디스플레이 라벨:
제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
---|---|---|---|---|---|---|
Verteporfin | 129497-78-5 | sc-475698 sc-475698A | 10 mg 100 mg | $347.00 $2710.00 | 5 | |
버테포핀은 "Or1e34"와 같은 유전자 조절과 연결된 히포 경로에 영향을 줄 수 있습니다. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
라파마이신은 mTOR을 억제하며, 그 변조는 "Or1e34"와 관련된 신호 경로에 간접적으로 영향을 미칠 수 있습니다. |